61 related articles for article (PubMed ID: 15973993)
1. [Eukaryotic expression and functional characterization of PD-1 extracellular domain].
He YF; Zhang GM; Wang XH; Zhang H; Yuan Y; Li D; Feng ZH
Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):699-703. PubMed ID: 15973993
[TBL] [Abstract][Full Text] [Related]
2. Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma.
He L; Zhang G; He Y; Zhu H; Zhang H; Feng Z
Anticancer Res; 2005; 25(5):3309-13. PubMed ID: 16101143
[TBL] [Abstract][Full Text] [Related]
3. Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine.
He YF; Zhang GM; Wang XH; Zhang H; Yuan Y; Li D; Feng ZH
J Immunol; 2004 Oct; 173(8):4919-28. PubMed ID: 15470033
[TBL] [Abstract][Full Text] [Related]
4. Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells.
Liu Y; Yu Y; Yang S; Zeng B; Zhang Z; Jiao G; Zhang Y; Cai L; Yang R
Cancer Immunol Immunother; 2009 May; 58(5):687-97. PubMed ID: 18828017
[TBL] [Abstract][Full Text] [Related]
5. [Expression of human PD-1Deltaex3 and primary study of its biological activity].
Hu ZH; Chen YJ; Wang Q; Shi BM; Bai LX; Zhang XG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):207-10. PubMed ID: 20230680
[TBL] [Abstract][Full Text] [Related]
6. Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice.
Cao J; Liu FX; Yu MX
Chin Med J (Engl); 2009 Aug; 122(16):1941-6. PubMed ID: 19781375
[TBL] [Abstract][Full Text] [Related]
7. Regulating immunity and inhibiting tumor growth by the recombinant peptide sPD-1-CH50.
Qiu H; Liu S; Xie C; Long J; Feng Z
Anticancer Res; 2009 Dec; 29(12):5089-94. PubMed ID: 20044621
[TBL] [Abstract][Full Text] [Related]
8. [Soluble PD-1 can augment anti-tumor immunity induced by HSP70-peptide complex in tumor-bearing mice].
Wang XH; Zhang GM; He YF; Zhang H; Feng ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):655-8. PubMed ID: 15555427
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effects of simultaneous expression of 4-1BBL and sPD-1 on experimental murine hepatoma].
Qiu H; Zhang H; Feng ZH; Geng H; Zhang GM
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):505-9. PubMed ID: 16867271
[TBL] [Abstract][Full Text] [Related]
10. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.
Blank C; Gajewski TF; Mackensen A
Cancer Immunol Immunother; 2005 Apr; 54(4):307-14. PubMed ID: 15599732
[TBL] [Abstract][Full Text] [Related]
11. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
[TBL] [Abstract][Full Text] [Related]
12. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.
Tsushima F; Iwai H; Otsuki N; Abe M; Hirose S; Yamazaki T; Akiba H; Yagita H; Takahashi Y; Omura K; Okumura K; Azuma M
Eur J Immunol; 2003 Oct; 33(10):2773-82. PubMed ID: 14515261
[TBL] [Abstract][Full Text] [Related]
13. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
Currie AJ; Prosser A; McDonnell A; Cleaver AL; Robinson BW; Freeman GJ; van der Most RG
J Immunol; 2009 Dec; 183(12):7898-908. PubMed ID: 20007574
[TBL] [Abstract][Full Text] [Related]
14. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
[TBL] [Abstract][Full Text] [Related]
16. Expression and purification of soluble human programmed death-1 in Escherichia coli.
Xu L; Liu Y; He X
Cell Mol Immunol; 2006 Apr; 3(2):139-43. PubMed ID: 16696901
[TBL] [Abstract][Full Text] [Related]
17. Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.
Karim R; Jordanova ES; Piersma SJ; Kenter GG; Chen L; Boer JM; Melief CJ; van der Burg SH
Clin Cancer Res; 2009 Oct; 15(20):6341-7. PubMed ID: 19825956
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.
del Rio ML; Penuelas-Rivas G; Dominguez-Perles R; Ramirez P; Parrilla P; Rodriguez-Barbosa JI
Eur J Immunol; 2005 Dec; 35(12):3545-60. PubMed ID: 16285013
[TBL] [Abstract][Full Text] [Related]
19. [Construction and expression of recombinant fusion of transmembrane programmed death ligand 1 and DsRed2].
Liao WJ; Sun J; Zhu HF; Zhang JY; Shen GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1068-71. PubMed ID: 18992194
[TBL] [Abstract][Full Text] [Related]
20. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
